EUVIMEDEUVIMED entdecken
Open Access

Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season

Jonathan H Pelletier, Sarah Z Rush, Eric Robinette, Danielle E Maholtz, Michael T Bigham, Michael L Forbes, Steven L Shein, Todd J Karsies, Christopher M Horvat

JAMA Network Open · 24.09.2025 · 8 (9) · e2533535

DOI: 10.1001/jamanetworkopen.2025.33535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 24.09.2025. Verfasst von Jonathan H Pelletier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Critical Care Medicine, Department of Pediatrics, Akron Children's, Akron, Ohio. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cohort study examines rates of hospitalization associated with respiratory syncytial virus (RSV) among infants by nirsevimab administration during the 2024-2025 season.

Autor:innen und Institutionen

  • Division of Critical Care Medicine, Department of Pediatrics, Akron Children's, Akron, Ohio.
  • Department of Pediatrics, College of Medicine, Northeast Ohio Medical University, Rootstown.
  • Division of Hematology and Oncology, Department of Pediatrics, Akron Children's, Akron, Ohio.
  • Division of Infectious Disease, Department of Pediatrics, Akron Children's, Akron, Ohio.
  • The Rebecca D Considine Research Institute, Akron Children's, Akron, Ohio.
  • Division of Critical Care Medicine, Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, Ohio.

Zitieren

APA

Pelletier, J. H., Rush, S. Z., Robinette, E., Maholtz, D. E., Bigham, M. T., Forbes, M. L., Shein, S. L., Karsies, T. J., & Horvat, C. M. (2025). Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season. JAMA Network Open, 8(9), e2533535. https://doi.org/10.1001/jamanetworkopen.2025.33535

Vancouver

Pelletier JH, Rush SZ, Robinette E, Maholtz DE, Bigham MT, Forbes ML, et al. Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season. JAMA Network Open. 2025;8(9):e2533535. doi:10.1001/jamanetworkopen.2025.33535

BibTeX
@article{Pelletier2025,
  author = {Pelletier, Jonathan H and Rush, Sarah Z and Robinette, Eric and Maholtz, Danielle E and Bigham, Michael T and Forbes, Michael L and Shein, Steven L and Karsies, Todd J and Horvat, Christopher M},
  title = {Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {9},
  pages = {e2533535},
  doi = {10.1001/jamanetworkopen.2025.33535}
}
Kostenlos starten →